Research Frontiers in TGFB1 Variants in Chemotherapy-Induced Pulmonary Fibrosis
Examination of transforming growth factor-beta 1 genetic polymorphisms as risk factors for bleomycin and taxane-induced pulmonary fibrosis development during cancer treatment.